arrow
A

Anton Y. Peleg

monash university
H指数:69
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population pharmacokinetics of daptomycin in patients with haematological malignancies and vancomycin-resistant Enterococcus bloodstream infections

达托霉素在血液系统恶性肿瘤合并耐万古霉素肠球菌血流感染患者中的群体药代动力学

2026-08-240
PRE
Bacterial Carriage and Invasive Infections Among People Who Inject Drugs: Clinical and Molecular Epidemiology in an Australian Prospective Cohort

注射药物人群中的细菌携带和侵袭性感染:澳大利亚前瞻性队列的临床和分子流行病学

2026-08-060
OAAI
Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure

交叉反应性抗噬菌体抗体和与噬菌体治疗失败有关的细菌异质性

2026-04-240
PRE
Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and Targeting

载达托霉素纳米载体通过脂质介导的相互作用和靶向作用促进甲氧西林耐药金黄色葡萄球菌的协同杀灭。

2025-11-010
OAAI
Mortality and length of stay associated with antimicrobial-susceptible and -resistant hospital-onset bloodstream infections at a tertiary referral hospital in Melbourne, Australia

在澳大利亚墨尔本一家三级转诊医院中,与抗菌药物敏感型和耐药型院内血流感染相关的死亡率和住院时间

2025-10-010
OAAI
Complex pathways to ceftolozane-tazobactam resistance in clinical Pseudomonas aeruginosa isolates: a genomic epidemiology study

铜绿假单胞菌临床分离株中导致他唑巴坦-头孢他洛星耐药的复杂通路:一项基因组流行病学研究

2025-09-260
PRE
Low bacterial metabolism as a central mechanism of antimicrobial resistance and potential therapeutic target of staphylococcal biofilms in ventricular assist device driveline infections

低细菌代谢作为抗菌耐药性的核心机制,以及心室辅助装置驱动线感染中金黄色葡萄球菌生物膜潜在的 therapeutic target。

2025-08-010
PRE